Ayala Pharmaceuticals Inc (ADXS)

[cab033]

Fbg, of course I have a problem with what it appears he has been doing. I didn't like it every time he pulled one of his stunts allowing more RSU's to go in his pocket for performance he did not earn and it bothers me even more know. At this very moment I am studying for the cpa exam and over the last couple weeks I have been on chapters relating to corporate governance and fiduciary responsibility and ways to use pay compensation strategies to accomplish company goals and management performance, and I am now on cost of capital and ROE. As I go through these topics and think back over the years about how DO has handled many different items, it really looks back on Dan as a CEO. As a SH we have always given him the benefit of the doubt because we are thinking about future wealth, but as an auditor which is what I am, it does not look good from this side. We keep justifying his selfish acts but I feel like that is getting tougher to do as time goes by.

Hypothetically just think if 2017 goes just like 2016 did, how will this board feel about Dan then? 2016 had some big things happen and some good data and partnerships, but no sp appreciation. This year could follow that trend and we could be in this price range with more good data, more partnerships, and more shares outstanding 1 year from now. But Dan would have another $100k-200k worth of shares. But back to your question, yes I have a problem with his actions but there is nothing I can do about it but keep waiting for something to change.